Intravenous valproate for treatment of status migrainosus in the headache clinic: A retrospective look

Headache and Pain: Diagnostic Challenges, Current Therapy

Volumn 17, Issue 3, 2006, Pages 121-123

  Krusz, John Claude ^a   Cagle, Jane ^a   Scott, Virginia ^a  

^a Anodyne Headache and PainCare   (United States)

Author keywords

Intravenous valproate sodium; Status migrainosus

Indexed keywords

ERGOTAMINE DERIVATIVE; OPIATE DERIVATIVE; TRIPTAN DERIVATIVE; VALPROIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; DISEASE DURATION; DISEASE SEVERITY; DROWSINESS; DRUG EFFICACY; DRUG SAFETY; FEMALE; HOSPITALIZATION; HUMAN; MALE; MIGRAINE; PAIN ASSESSMENT; PRIORITY JOURNAL; RATING SCALE; RETROSPECTIVE STUDY; SELF EVALUATION; TREATMENT OUTCOME;

EID: 33750492315     PISSN: 15458261     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Freitag FG, Collins SD, Carlson HA, et al. A randomized trial of divalproex sodium extended-release tablets in migraine prophylaxis. Neurology. 2002;58:1652-1659.
2. Silberstein SD, Collins SD. Safety of divalproex sodium in migraine prophylaxis: an open-label, long-term study. Long-term Safety of Depakote in Headache Prophylaxis Study Group. Headache. 1999;39:633-643.
3. Kaniecki RG. A comparison of divalproex with propranolol and placebo for the prophylaxis of migraine without aura. Arch Neurol. 1997;54:1141-1145.
4. Ghose K, Niven B. Prophylactic sodium valproate therapy in patients with drug-resistant migraine. Methods Find Exp Clin Pharmacol. 1998;20:353-359.
5. Mitsikostas DD, Polychronidis I. Valproate versus flunarizine in migraine prophylaxis: a randomized, double-open clinical trial. Funct Neural. 1997;12:267-276.
6. Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study [published correction appears in Cephalalgia. 1997;17:798]. Cephalalgia. 1997;17:103-108.
7. Jensen R, Brinck T, Olesen J. Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology. 1994;44:647-651.
8. Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia. 1992;12:81-84.
9. Depacon® (valproate sodium) [prescribing information]. North Chicago, Ill: Abbott Laboratories; 2002.
10. Krusz JC, Belanger J. Intravenous magnesium sulfate in the treatment of headaches. In: Program and abstracts of the Annual Meeting of the American Academy of Pain Management; September 1998; Atlanta.
11. Krusz JC, Belanger J. IV droperidol: a highly effective agent for the treatment of acute intractable migraine headaches. In: Program and abstracts of the Annual Meeting of the International Headache Society World Congress; June 1999; Barcelona, Spain.
12. Krusz JC, Scott V, Belanger J. Intravenous propofol: unique effectiveness in treating intractable migraine. Headache. 2000;40:224-230.
13. Krusz JC. Intravenous valproate sodium in the treatment of migraines in the headache clinic. Cephalalgia. 2001;21:433-439.
14. Headache Classification Committee for the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia. 1988;8(suppl 7):1-96.
15. Edwards KR, Norton J, Behnke M. Comparison of intravenous valproate versus intramuscular dihydroergotamine and metoclopramide for acute treatment of migraine headache. Headache. 2001;41:976-980.
16. Mathew NT, Kailasam J, Meadors L, et al. Intravenous valproate sodium (depacon) aborts migraine rapidly: a preliminary report. Headache. 2000;40:720-723.
17. Norton J. Use of intravenous valproate sodium in status migraine. Headache. 2000;40:755-757.
18. Kozubski W, Prusinski A. The comparison of sodium valproate and ergotamine titrate plus caffeine in the abortive treatment of migraine attacks. Neurol Neurochir Pol. 1995;29:929-935.
19. Stillman MJ, Zajac D, Rybicki LA. Treatment of primary headache disorders with intravenous valproate: initial outpatient experience. Headache. 2004;44:65-69.
20. Lipton RB, Stewart WF, Scher AI. Epidemiology and economic impact of migraine. Curr Med Res Opin. 2001;17(suppl 1):s4-s12.